Consistently, the diabetes incidence in both TRM cell depleted FABP4+/+ NOD mice (52.85%) and FABP4−/− NOD mice receiving IgG (43.73%) at 30 weeks old were significantly attenuated when compared to FABP4+/+ NOD mice receiving IgG (75.83%) (Figure 5C). Here, FABP4 is linked to diabetes mellitus.